Quest Diagnostics Inc (NYSE:DGX)
| 133.81 Delayed Data As of May 26 |  +1.12 / +0.84%Today’s Change | 120.40 Today|||52-Week Range 158.34 | -14.47% Year-to-Date |
Latest DGX News | Press Releases
| Want Growing Passive Income? Consider Buying This Stock May 24 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 132.69 |
| Today’s open | 133.00 |
| Day’s range | 132.91 - 134.43 |
| Volume | 1,058,460 |
| Average volume (3 months) | 1,101,801 |
| Market cap | $15.0B |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -48.94% |
| Earnings growth (this year) | -12.27% |
| Earnings growth (next 5 years) | -1.02% |
| Revenue growth (last year) | -8.39% |
| P/E ratio | 19.6 |
| Price/Sales | 1.87 |
| Price/Book | 2.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LHLaboratory Corporati... | +2.27 | +1.06% |
| NTRANatera Inc | +0.39 | +0.81% |
| GHGuardant Health Inc | +0.22 | +0.79% |
| ---- |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | July 25, 2023 |
| EPS forecast (this quarter) | $2.28 |
| Annual revenue (last year) | $9.9B |
| Annual profit (last year) | $942.0M |
| Net profit margin | 9.53% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
No executives to display |
Corporate headquarters Secaucus, New Jersey |
Forecasts
